Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2001 Feb;84(2):169–173. doi: 10.1136/adc.84.2.169

Severe combined immunodeficiency—molecular pathogenesis and diagnosis

H Gaspar 1, K Gilmour 1, A Jones 1
PMCID: PMC1718644  PMID: 11159300

Full Text

The Full Text of this article is available as a PDF (133.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agrawal A., Schatz D. G. RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell. 1997 Apr 4;89(1):43–53. doi: 10.1016/s0092-8674(00)80181-6. [DOI] [PubMed] [Google Scholar]
  2. Alarcon B., Regueiro J. R., Arnaiz-Villena A., Terhorst C. Familial defect in the surface expression of the T-cell receptor-CD3 complex. N Engl J Med. 1988 Nov 3;319(18):1203–1208. doi: 10.1056/NEJM198811033191806. [DOI] [PubMed] [Google Scholar]
  3. Arpaia E., Shahar M., Dadi H., Cohen A., Roifman C. M. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell. 1994 Mar 11;76(5):947–958. doi: 10.1016/0092-8674(94)90368-9. [DOI] [PubMed] [Google Scholar]
  4. Arredondo-Vega F. X., Santisteban I., Daniels S., Toutain S., Hershfield M. S. Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. Am J Hum Genet. 1998 Oct;63(4):1049–1059. doi: 10.1086/302054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Arrendondo-Vega F. X., Santisteban I., Notarangelo L. D., El Dahr J., Buckley R., Roifman C., Conley M. E., Hershfield M. S. Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delG, and E337del. Mutations in brief no. 142. Online. Hum Mutat. 1998;11(6):482–482. doi: 10.1002/(SICI)1098-1004(1998)11:6<482::AID-HUMU15>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  6. Benveniste P., Zhu W., Cohen A. Interference with thymocyte differentiation by an inhibitor of S-adenosylhomocysteine hydrolase. J Immunol. 1995 Jul 15;155(2):536–544. [PubMed] [Google Scholar]
  7. Bogue M. A., Wang C., Zhu C., Roth D. B. V(D)J recombination in Ku86-deficient mice: distinct effects on coding, signal, and hybrid joint formation. Immunity. 1997 Jul;7(1):37–47. doi: 10.1016/s1074-7613(00)80508-7. [DOI] [PubMed] [Google Scholar]
  8. Bordignon C., Notarangelo L. D., Nobili N., Ferrari G., Casorati G., Panina P., Mazzolari E., Maggioni D., Rossi C., Servida P. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science. 1995 Oct 20;270(5235):470–475. doi: 10.1126/science.270.5235.470. [DOI] [PubMed] [Google Scholar]
  9. Bénichou B., Strominger J. L. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4285–4288. doi: 10.1073/pnas.88.10.4285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Candotti F., Oakes S. A., Johnston J. A., Giliani S., Schumacher R. F., Mella P., Fiorini M., Ugazio A. G., Badolato R., Notarangelo L. D. Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood. 1997 Nov 15;90(10):3996–4003. [PubMed] [Google Scholar]
  11. Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., Gross F., Yvon E., Nusbaum P., Selz F., Hue C., Certain S., Casanova J. L. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000 Apr 28;288(5466):669–672. doi: 10.1126/science.288.5466.669. [DOI] [PubMed] [Google Scholar]
  12. Cavazzana-Calvo M., Le Deist F., De Saint Basile G., Papadopoulo D., De Villartay J. P., Fischer A. Increased radiosensitivity of granulocyte macrophage colony-forming units and skin fibroblasts in human autosomal recessive severe combined immunodeficiency. J Clin Invest. 1993 Mar;91(3):1214–1218. doi: 10.1172/JCI116282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Clark P. A., Lester T., Genet S., Jones A. M., Hendriks R., Levinsky R. J., Kinnon C. Screening for mutations causing X-linked severe combined immunodeficiency in the IL-2R gamma chain gene by single-strand conformation polymorphism analysis. Hum Genet. 1995 Oct;96(4):427–432. doi: 10.1007/BF00191801. [DOI] [PubMed] [Google Scholar]
  14. Cohen A., Gudas L. J., Ammann A. J., Staal G. E., Martin D. W., Jr Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest. 1978 May;61(5):1405–1409. doi: 10.1172/JCI109058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Di Santo J. P., Colucci F., Guy-Grand D. Natural killer and T cells of innate and adaptive immunity: lymphoid compartments with different requirements for common gamma chain-dependent cytokines. Immunol Rev. 1998 Oct;165:29–38. doi: 10.1111/j.1600-065x.1998.tb01227.x. [DOI] [PubMed] [Google Scholar]
  16. Fischer A., Cavazzana-Calvo M., De Saint Basile G., DeVillartay J. P., Di Santo J. P., Hivroz C., Rieux-Laucat F., Le Deist F. Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol. 1997;15:93–124. doi: 10.1146/annurev.immunol.15.1.93. [DOI] [PubMed] [Google Scholar]
  17. Flake A. W., Roncarolo M. G., Puck J. M., Almeida-Porada G., Evans M. I., Johnson M. P., Abella E. M., Harrison D. D., Zanjani E. D. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med. 1996 Dec 12;335(24):1806–1810. doi: 10.1056/NEJM199612123352404. [DOI] [PubMed] [Google Scholar]
  18. Frank K. M., Sekiguchi J. M., Seidl K. J., Swat W., Rathbun G. A., Cheng H. L., Davidson L., Kangaloo L., Alt F. W. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature. 1998 Nov 12;396(6707):173–177. doi: 10.1038/24172. [DOI] [PubMed] [Google Scholar]
  19. Gao Y., Sun Y., Frank K. M., Dikkes P., Fujiwara Y., Seidl K. J., Sekiguchi J. M., Rathbun G. A., Swat W., Wang J. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell. 1998 Dec 23;95(7):891–902. doi: 10.1016/s0092-8674(00)81714-6. [DOI] [PubMed] [Google Scholar]
  20. Giblett E. R., Ammann A. J., Wara D. W., Sandman R., Diamond L. K. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet. 1975 May 3;1(7914):1010–1013. doi: 10.1016/s0140-6736(75)91950-9. [DOI] [PubMed] [Google Scholar]
  21. Goldman F. D., Ballas Z. K., Schutte B. C., Kemp J., Hollenback C., Noraz N., Taylor N. Defective expression of p56lck in an infant with severe combined immunodeficiency. J Clin Invest. 1998 Jul 15;102(2):421–429. doi: 10.1172/JCI3205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gu Y., Seidl K. J., Rathbun G. A., Zhu C., Manis J. P., van der Stoep N., Davidson L., Cheng H. L., Sekiguchi J. M., Frank K. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity. 1997 Nov;7(5):653–665. doi: 10.1016/s1074-7613(00)80386-6. [DOI] [PubMed] [Google Scholar]
  23. Hague R. A., Rassam S., Morgan G., Cant A. J. Early diagnosis of severe combined immunodeficiency syndrome. Arch Dis Child. 1994 Apr;70(4):260–263. doi: 10.1136/adc.70.4.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hershfield M. S. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy. Semin Hematol. 1998 Oct;35(4):291–298. [PubMed] [Google Scholar]
  25. Jeggo P. A. Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. Radiat Res. 1998 Nov;150(5 Suppl):S80–S91. [PubMed] [Google Scholar]
  26. Kung C., Pingel J. T., Heikinheimo M., Klemola T., Varkila K., Yoo L. I., Vuopala K., Poyhonen M., Uhari M., Rogers M. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med. 2000 Mar;6(3):343–345. doi: 10.1038/73208. [DOI] [PubMed] [Google Scholar]
  27. Macchi P., Villa A., Giliani S., Sacco M. G., Frattini A., Porta F., Ugazio A. G., Johnston J. A., Candotti F., O'Shea J. J. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature. 1995 Sep 7;377(6544):65–68. doi: 10.1038/377065a0. [DOI] [PubMed] [Google Scholar]
  28. Moore T. A., von Freeden-Jeffry U., Murray R., Zlotnik A. Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice. J Immunol. 1996 Sep 15;157(6):2366–2373. [PubMed] [Google Scholar]
  29. Morgan G., Levinsky R. J., Hugh-Jones K., Fairbanks L. D., Morris G. S., Simmonds H. A. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency. Clin Exp Immunol. 1987 Dec;70(3):491–499. [PMC free article] [PubMed] [Google Scholar]
  30. Nagarajan U. M., Louis-Plence P., DeSandro A., Nilsen R., Bushey A., Boss J. M. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity. 1999 Feb;10(2):153–162. doi: 10.1016/s1074-7613(00)80016-3. [DOI] [PubMed] [Google Scholar]
  31. Noguchi M., Yi H., Rosenblatt H. M., Filipovich A. H., Adelstein S., Modi W. S., McBride O. W., Leonard W. J. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993 Apr 9;73(1):147–157. doi: 10.1016/0092-8674(93)90167-o. [DOI] [PubMed] [Google Scholar]
  32. Ozsahin H., Arredondo-Vega F. X., Santisteban I., Fuhrer H., Tuchschmid P., Jochum W., Aguzzi A., Lederman H. M., Fleischman A., Winkelstein J. A. Adenosine deaminase deficiency in adults. Blood. 1997 Apr 15;89(8):2849–2855. [PubMed] [Google Scholar]
  33. Peake J., Waugh A., Le Deist F., Priestley A., Rieux-Laucat F., Foray N., Capulas E., Singleton B. K., de Villartay J. P., Cant A. Combined immunodeficiency associated with increased apoptosis of lymphocytes and radiosensitivity fibroblasts. Cancer Res. 1999 Jul 15;59(14):3454–3460. [PubMed] [Google Scholar]
  34. Puck J. M., Pepper A. E., Henthorn P. S., Candotti F., Isakov J., Whitwam T., Conley M. E., Fischer R. E., Rosenblatt H. M., Small T. N. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood. 1997 Mar 15;89(6):1968–1977. [PubMed] [Google Scholar]
  35. Rieux-Laucat F., Bahadoran P., Brousse N., Selz F., Fischer A., Le Deist F., De Villartay J. P. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome. J Clin Invest. 1998 Jul 15;102(2):312–321. doi: 10.1172/JCI332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Russell S. M., Tayebi N., Nakajima H., Riedy M. C., Roberts J. L., Aman M. J., Migone T. S., Noguchi M., Markert M. L., Buckley R. H. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science. 1995 Nov 3;270(5237):797–800. doi: 10.1126/science.270.5237.797. [DOI] [PubMed] [Google Scholar]
  37. Schwarz K., Gauss G. H., Ludwig L., Pannicke U., Li Z., Lindner D., Friedrich W., Seger R. A., Hansen-Hagge T. E., Desiderio S. RAG mutations in human B cell-negative SCID. Science. 1996 Oct 4;274(5284):97–99. doi: 10.1126/science.274.5284.97. [DOI] [PubMed] [Google Scholar]
  38. Sharfe N., Dadi H. K., Shahar M., Roifman C. M. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3168–3171. doi: 10.1073/pnas.94.7.3168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Soudais C., de Villartay J. P., Le Deist F., Fischer A., Lisowska-Grospierre B. Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency. Nat Genet. 1993 Jan;3(1):77–81. doi: 10.1038/ng0193-77. [DOI] [PubMed] [Google Scholar]
  40. Soutar R. L., Day R. E. Dysequilibrium/ataxic diplegia with immunodeficiency. Arch Dis Child. 1991 Aug;66(8):982–983. doi: 10.1136/adc.66.8.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Steimle V., Durand B., Barras E., Zufferey M., Hadam M. R., Mach B., Reith W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 1995 May 1;9(9):1021–1032. doi: 10.1101/gad.9.9.1021. [DOI] [PubMed] [Google Scholar]
  42. Steimle V., Otten L. A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 1993 Oct 8;75(1):135–146. [PubMed] [Google Scholar]
  43. Suzuki H., Duncan G. S., Takimoto H., Mak T. W. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J Exp Med. 1997 Feb 3;185(3):499–505. doi: 10.1084/jem.185.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Taccioli G. E., Amatucci A. G., Beamish H. J., Gell D., Xiang X. H., Torres Arzayus M. I., Priestley A., Jackson S. P., Marshak Rothstein A., Jeggo P. A. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity. 1998 Sep;9(3):355–366. doi: 10.1016/s1074-7613(00)80618-4. [DOI] [PubMed] [Google Scholar]
  45. Tam D. A., Jr, Leshner R. T. Stroke in purine nucleoside phosphorylase deficiency. Pediatr Neurol. 1995 Feb;12(2):146–148. doi: 10.1016/0887-8994(94)00118-l. [DOI] [PubMed] [Google Scholar]
  46. Thomis D. C., Berg L. J. The role of Jak3 in lymphoid development, activation, and signaling. Curr Opin Immunol. 1997 Aug;9(4):541–547. doi: 10.1016/s0952-7915(97)80108-2. [DOI] [PubMed] [Google Scholar]
  47. Villa A., Santagata S., Bozzi F., Giliani S., Frattini A., Imberti L., Gatta L. B., Ochs H. D., Schwarz K., Notarangelo L. D. Partial V(D)J recombination activity leads to Omenn syndrome. Cell. 1998 May 29;93(5):885–896. doi: 10.1016/s0092-8674(00)81448-8. [DOI] [PubMed] [Google Scholar]
  48. Villard J., Lisowska-Grospierre B., van den Elsen P., Fischer A., Reith W., Mach B. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N Engl J Med. 1997 Sep 11;337(11):748–753. doi: 10.1056/NEJM199709113371104. [DOI] [PubMed] [Google Scholar]
  49. White H., Thrasher A., Veys P., Kinnon C., Gaspar H. B. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency. Eur J Immunol. 2000 Mar;30(3):732–737. doi: 10.1002/1521-4141(200003)30:3<732::AID-IMMU732>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  50. de Saint-Basile G., Le Deist F., de Villartay J. P., Cerf-Bensussan N., Journet O., Brousse N., Griscelli C., Fischer A. Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). J Clin Invest. 1991 Apr;87(4):1352–1359. doi: 10.1172/JCI115139. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES